InvestorsHub Logo
Followers 209
Posts 32156
Boards Moderated 1
Alias Born 06/30/2009

Re: farrell90 post# 387539

Wednesday, 01/26/2022 4:25:13 PM

Wednesday, January 26, 2022 4:25:13 PM

Post# of 403019
"Let me know if you find one with where government sponsored in vitro testing against Covid produced a selectivity index of 426."Why would I do that? Hasn't that "feature" of brilacidin already shown its lack of significance?

"I believe IPIX, as it has stated publicly, is actively pursuing inclusion in the ACTIV trials."
Is that what you call this?
"Topline results for the Phase 2 Brilacidin COVID-19 clinical trial (see NCT04784897) have been reported. Complete analysis of trial results already has begun, with the aim to potentially identify positive trends in the data that could support Brilacidin for inclusion in larger COVID-19 platform trials, such as the U.K.’s CTAP program and the NIH’s ACTIV program."

I saw no other reference to the ACTIV trials. They weren't mentioned in today's update.


Could the NIH be expected to fund B's inclusion in a trial given the recent reported results?

Or are you relying on your last ditch theory and dismissing those results?
"These drugs are a last ditch effort by the NIH to find any drug with any degree of efficacy against Covid."

Would I be mistaken in saying that Brilacidin has yet to show any degree of efficacy against Covid in humans?

I'm tryin ta think but nuttin happens......Curly

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News